Claudia Suessmuth-Dyckerhoff

Claudia Suessmuth-Dyckerhoff is a prominent figure in the healthcare and corporate governance sectors, currently serving as a Member of the Board at Roche since March 2016. She holds a significant role in various organizations, including being a board member of Clariant, Ramsay Health Care, and Prudential plc. Her extensive experience in healthcare consulting and strategy development is rooted in her long tenure at McKinsey & Company, where she worked for over two decades, ultimately becoming a Senior Partner and leading the Asia Health Systems and Services sector until 2016.123

Educational Background

• PhD in Business Administration: University of St. Gallen/University of Michigan Ann Arbor
• MBA: CEMS/ESADE, Barcelona
• Early Career: Trained as a banker at Deutsche Bank before transitioning to consulting.26

Professional Experience

• McKinsey & Company (1995-2016): Joined as a consultant focusing on healthcare; held various leadership roles including Senior Partner.
• Roche: Board Member since March 2016; involved in the Corporate Governance and Sustainability Committee.34
• Clariant: Board Member since April 2016; serves on the Compensation Committee.5
• Ramsay Health Care: Joined the board in November 2018, contributing expertise in market growth strategies and operational performance improvement.15
• Prudential plc: Board Member since January 2023.2

Contributions and Interests

Claudia is passionate about improving healthcare systems globally and has published various articles related to healthcare. Her work often focuses on market entry strategies, business development, and operational excellence within the healthcare sector across Europe, Asia, and the United States.134 She is also involved with several non-profit organizations aimed at supporting underprivileged children and healthcare initiatives in Asia.26

Personal Life

Claudia Suessmuth-Dyckerhoff is married and has five children. Her diverse background and leadership roles position her as an influential voice in both corporate governance and healthcare improvement efforts globally.35